Literature DB >> 33980591

Differential Inhibition of HIV Replication by the 12 Interferon Alpha Subtypes.

Armando Espinosa Ortiz1,2,3, Olivia Blake2,3, Alexandra Tauzin1,2,3, Calaiselvy Soundaramourty1,3, Charles Joly-Beauparlant4, Alexandre Nicolas1,2,3, Arnaud Droit4, Jacques Dutrieux2,5, Jérôme Estaquier1,3,4, Fabrizio Mammano1,2,3.   

Abstract

Type I interferons (IFNs) are a family of cytokines that represent a first line of defense against virus infections. The 12 different IFN-α subtypes share a receptor on target cells and trigger similar signaling cascades. Several studies have collectively shown that this apparent redundancy conceals qualitatively different responses induced by individual subtypes, which display different efficacies of inhibition of HIV replication. Some studies, however, provided evidence that the disparities are quantitative rather than qualitative. Since RNA expression analyses show a large but incomplete overlap of the genes induced, they may support both models. To explore if the IFN-α subtypes induce functionally relevant different anti-HIV activities, we have compared the efficacies of inhibition of all 12 subtypes on HIV spread and on specific steps of the viral replication cycle, including viral entry, reverse transcription, protein synthesis, and virus release. Finding different hierarchies of inhibition would validate the induction of qualitatively different responses. We found that while most subtypes similarly inhibit virus entry, they display distinctive potencies on other early steps of HIV replication. In addition, only some subtypes were able to target effectively the late steps. The extent of induction of known anti-HIV factors helps to explain some, but not all differences observed, confirming the participation of additional IFN-induced anti-HIV effectors. Our findings support the notion that different IFN-α subtypes can induce the expression of qualitatively different antiviral activities. IMPORTANCE The initial response against viruses relies in large part on type I interferons, which include 12 subtypes of IFN-α. These cytokines bind to a common receptor on the cell surface and trigger the expression of incompletely overlapping sets of genes. Whether the anti-HIV responses induced by IFN-α subtypes differ in the extent of expression or in the nature of the genes involved remains debated. Also, RNA expression profiles led to opposite conclusions, depending on the importance attributed to the induction of common or distinctive genes. To explore if relevant anti-HIV activities can be differently induced by the IFN-α subtypes, we compared their relative efficacies on specific steps of the replication cycle. We show that the hierarchy of IFN potencies depends on the step analyzed, supporting qualitatively different responses. This work will also prompt the search for novel IFN-induced anti-HIV factors acting on specific steps of the replication cycle.

Entities:  

Keywords:  HIV-1; IFN subtypes; type I IFN; virus replication

Mesh:

Substances:

Year:  2021        PMID: 33980591      PMCID: PMC8274621          DOI: 10.1128/JVI.02311-20

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  96 in total

1.  Guanylate-Binding Proteins 2 and 5 Exert Broad Antiviral Activity by Inhibiting Furin-Mediated Processing of Viral Envelope Proteins.

Authors:  Elisabeth Braun; Dominik Hotter; Lennart Koepke; Fabian Zech; Rüdiger Groß; Konstantin M J Sparrer; Janis A Müller; Christian K Pfaller; Elena Heusinger; Rebecka Wombacher; Kathrin Sutter; Ulf Dittmer; Michael Winkler; Graham Simmons; Martin R Jakobsen; Karl-Klaus Conzelmann; Stefan Pöhlmann; Jan Münch; Oliver T Fackler; Frank Kirchhoff; Daniel Sauter
Journal:  Cell Rep       Date:  2019-05-14       Impact factor: 9.423

2.  A diverse range of gene products are effectors of the type I interferon antiviral response.

Authors:  John W Schoggins; Sam J Wilson; Maryline Panis; Mary Y Murphy; Christopher T Jones; Paul Bieniasz; Charles M Rice
Journal:  Nature       Date:  2011-04-10       Impact factor: 49.962

3.  Guanylate binding protein 5: Impairing virion infectivity by targeting retroviral envelope glycoproteins.

Authors:  Dominik Hotter; Daniel Sauter; Frank Kirchhoff
Journal:  Small GTPases       Date:  2016-06-08

4.  Different antiviral effects of IFNα subtypes in a mouse model of HBV infection.

Authors:  Jingjiao Song; Sheng Li; Yun Zhou; Jia Liu; Sandra Francois; Mengji Lu; Dongliang Yang; Ulf Dittmer; Kathrin Sutter
Journal:  Sci Rep       Date:  2017-03-23       Impact factor: 4.379

5.  Different Biological Activities of Specific Interferon Alpha Subtypes.

Authors:  Kim J Hasenkrug; Kerry J Lavender; Mario L Santiago; Kathrin Sutter; Ulf Dittmer
Journal:  mSphere       Date:  2019-07-24       Impact factor: 4.389

6.  SERINC3 and SERINC5 restrict HIV-1 infectivity and are counteracted by Nef.

Authors:  Yoshiko Usami; Yuanfei Wu; Heinrich G Göttlinger
Journal:  Nature       Date:  2015-09-30       Impact factor: 49.962

7.  Relative resistance of HIV-1 founder viruses to control by interferon-alpha.

Authors:  Angharad E Fenton-May; Oliver Dibben; Tanja Emmerich; Haitao Ding; Katja Pfafferott; Marlen M Aasa-Chapman; Pierre Pellegrino; Ian Williams; Myron S Cohen; Feng Gao; George M Shaw; Beatrice H Hahn; Christina Ochsenbauer; John C Kappes; Persephone Borrow
Journal:  Retrovirology       Date:  2013-12-03       Impact factor: 4.602

8.  Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 infection.

Authors:  Caroline Goujon; Olivier Moncorgé; Hélène Bauby; Tomas Doyle; Christopher C Ward; Torsten Schaller; Stéphane Hué; Wendy S Barclay; Reiner Schulz; Michael H Malim
Journal:  Nature       Date:  2013-09-18       Impact factor: 49.962

Review 9.  Type I Interferon Responses by HIV-1 Infection: Association with Disease Progression and Control.

Authors:  Andrew Soper; Izumi Kimura; Shumpei Nagaoka; Yoriyuki Konno; Keisuke Yamamoto; Yoshio Koyanagi; Kei Sato
Journal:  Front Immunol       Date:  2018-01-15       Impact factor: 7.561

10.  Antiviral potential of human IFN-α subtypes against influenza A H3N2 infection in human lung explants reveals subtype-specific activities.

Authors:  Aline da Rocha Matos; Katharina Wunderlich; Sebastian Schloer; Klaus Schughart; Robert Geffers; Martine Seders; Marlous de Witt; Anmari Christersson; Rainer Wiewrodt; Karsten Wiebe; Peter Barth; Andreas Hocke; Stefan Hippenstiel; Katja Hönzke; Ulf Dittmer; Kathrin Sutter; Ursula Rescher; Svetlana Rodionycheva; Nicoletta Matera; Stephan Ludwig; Linda Brunotte
Journal:  Emerg Microbes Infect       Date:  2019       Impact factor: 7.163

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.